These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15629365)

  • 1. Direct stenting of native de novo coronary artery lesions with the sirolimus-eluting stent: a post hoc subanalysis of the pooled E- and C-SIRIUS trials.
    Schlüter M; Schofer J; Gershlick AH; Schampaert E; Wijns W; Breithardt G;
    J Am Coll Cardiol; 2005 Jan; 45(1):10-3. PubMed ID: 15629365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
    Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-specific outcomes after sirolimus-eluting stent implantation.
    Solinas E; Nikolsky E; Lansky AJ; Kirtane AJ; Morice MC; Popma JJ; Schofer J; Schampaert E; Pucelikova T; Aoki J; Fahy M; Dangas GD; Moses JW; Cutlip DE; Leon MB; Mehran R
    J Am Coll Cardiol; 2007 Nov; 50(22):2111-6. PubMed ID: 18036446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.
    Weisz G; Leon MB; Holmes DR; Kereiakes DJ; Clark MR; Cohen BM; Ellis SG; Coleman P; Hill C; Shi C; Cutlip DE; Kuntz RE; Moses JW
    J Am Coll Cardiol; 2006 Apr; 47(7):1350-5. PubMed ID: 16580520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).
    Schampaert E; Cohen EA; Schlüter M; Reeves F; Traboulsi M; Title LM; Kuntz RE; Popma JJ;
    J Am Coll Cardiol; 2004 Mar; 43(6):1110-5. PubMed ID: 15028375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
    Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
    Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.
    Park KW; Chae IH; Lim DS; Han KR; Yang HM; Lee HY; Kang HJ; Koo BK; Ahn T; Yoon JH; Jeong MH; Hong TJ; Chung WY; Jo SH; Choi YJ; Hur SH; Kwon HM; Jeon DW; Kim BO; Park SH; Lee NH; Jeon HK; Gwon HC; Jang YS; Kim HS
    J Am Coll Cardiol; 2011 Oct; 58(18):1844-54. PubMed ID: 22018294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
    Chacko R; Mulhearn M; Novack V; Novack L; Mauri L; Cohen SA; Moses J; Leon MB; Cutlip DE
    JACC Cardiovasc Interv; 2009 Jun; 2(6):498-503. PubMed ID: 19539252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very long sirolimus-eluting stent implantation for de novo coronary lesions.
    Degertekin M; Arampatzis CA; Lemos PA; Saia F; Hoye A; Daemen J; Tanabe K; Lee CH; Hofma SJ; Sianos G; McFadden E; van der Giessen W; Smits PC; de Feyter PJ; van Domburg RT; Serruys PW
    Am J Cardiol; 2004 Apr; 93(7):826-9. PubMed ID: 15050483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
    Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
    Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.
    Kandzari DE; Leon MB; Popma JJ; Fitzgerald PJ; O'Shaughnessy C; Ball MW; Turco M; Applegate RJ; Gurbel PA; Midei MG; Badre SS; Mauri L; Thompson KP; LeNarz LA; Kuntz RE;
    J Am Coll Cardiol; 2006 Dec; 48(12):2440-7. PubMed ID: 17174180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials.
    Hoffmann R; Morice MC; Moses JW; Fitzgerald PJ; Mauri L; Breithardt G; Schofer J; Serruys PW; Stoll HP; Leon MB
    Heart; 2008 Mar; 94(3):322-8. PubMed ID: 17761505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.
    Park SJ; Kim YH; Lee BK; Lee SW; Lee CW; Hong MK; Kim JJ; Mintz GS; Park SW
    J Am Coll Cardiol; 2005 Feb; 45(3):351-6. PubMed ID: 15680711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT).
    Thuesen L; Kelbaek H; Kløvgaard L; Helqvist S; Jørgensen E; Aljabbari S; Krusell LR; Jensen GV; Bøtker HE; Saunamäki K; Lassen JF; van Weert A;
    Am Heart J; 2006 Dec; 152(6):1140-5. PubMed ID: 17161067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.